Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Tumor-Associated Macrophages as a Potential Strategy to Enhance the Response to Immune Checkpoint Inhibitors
Luca Cassetta, Takanori Kitamura
Frontiers in Cell and Developmental Biology (2018) Vol. 6
Open Access | Times Cited: 188

Showing 1-25 of 188 citing articles:

Tumor microenvironment complexity and therapeutic implications at a glance
Roghayyeh Baghban, Leila Roshangar, Rana Jahanban‐Esfahlan, et al.
Cell Communication and Signaling (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 1377
Navigating CAR-T cells through the solid-tumour microenvironment
Andrew J. Hou, Laurence C. Chen, Yvonne Y. Chen
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 7, pp. 531-550
Open Access | Times Cited: 370
Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression
Lucile Vanhersecke, Maxime Brunet, Jean‐Philippe Guégan, et al.
Nature Cancer (2021) Vol. 2, Iss. 8, pp. 794-802
Open Access | Times Cited: 359
Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
Qingyang Lei, Dan Wang, Kai Sun, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 329
T Cell Dysfunction and Exhaustion in Cancer
Zhen Zhang, Shasha Liu, Bin Zhang, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 304
PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
Jiaqiang Ma, Bohao Zheng, Shyamal Goswami, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 261
Tumor Immune Microenvironment during Epithelial–Mesenchymal Transition
Mana Taki, Kaoru Abiko, Masayo Ukita, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 17, pp. 4669-4679
Open Access | Times Cited: 234
HBEGF + macrophages in rheumatoid arthritis induce fibroblast invasiveness
David Kuo, Jennifer Ding, Ian S. Cohn, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 491
Open Access | Times Cited: 192
Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape
Constance J. Martin, Abhishek Datta, Christopher Littlefield, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 536
Closed Access | Times Cited: 189
Activating a collaborative innate-adaptive immune response to control metastasis
Lijuan Sun, Tim Kees, Ana S. Almeida, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1361-1374.e9
Open Access | Times Cited: 186
If we build it they will come: targeting the immune response to breast cancer
Margaret E. Gatti‐Mays, Justin M. Balko, Sofia R. Gameiro, et al.
npj Breast Cancer (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 170
CSF1R‐ and SHP2‐Inhibitor‐Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor‐Associated Macrophages
Anujan Ramesh, Sahana Kumar, Dipika Nandi, et al.
Advanced Materials (2019) Vol. 31, Iss. 51
Closed Access | Times Cited: 163
Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1
Cecilia Roux, Soode Moghadas Jafari, Rahul Shinde, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 10, pp. 4326-4335
Open Access | Times Cited: 162
Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity
Sushrut Kamerkar, Charan Leng, Olga Burenkova, et al.
Science Advances (2022) Vol. 8, Iss. 7
Open Access | Times Cited: 160
Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient
Hye Won Lee, Woosung Chung, Hae‐Ock Lee, et al.
Genome Medicine (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 155
CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities
Lionel Aurelien Kankeu Fonkoua, Olivia Sirpilla, Reona Sakemura, et al.
Molecular Therapy — Oncolytics (2022) Vol. 25, pp. 69-77
Open Access | Times Cited: 148
Myeloid cell-targeted therapies for solid tumours
Sangeeta Goswami, Swetha Anandhan, Deblina Raychaudhuri, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 106-120
Closed Access | Times Cited: 144
Tumor immune microenvironment in head and neck cancers
Samantha M. Y. Chen, Alexandra L. Krinsky, Rachel A. Woolaver, et al.
Molecular Carcinogenesis (2020) Vol. 59, Iss. 7, pp. 766-774
Open Access | Times Cited: 139
A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications
Sahar Sedighzadeh, Amin Pastaki Khoshbin, Sepideh Razi, et al.
Translational Lung Cancer Research (2021) Vol. 10, Iss. 4, pp. 1889-1916
Open Access | Times Cited: 127
Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy
Yu-Chen Wang, Xi Wang, Jiaji Yu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 113
Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer
Michela Masetti, Roberta Carriero, Federica Portale, et al.
The Journal of Experimental Medicine (2021) Vol. 219, Iss. 2
Open Access | Times Cited: 112
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment
Clelia Madeddu, Clelia Donisi, Nicole Liscia, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6489-6489
Open Access | Times Cited: 82
New clinical trial design in precision medicine: discovery, development and direction
Xiao-Peng Duan, Bao‐Dong Qin, Xiao‐Dong Jiao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 49
Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy
Belén Toledo, Linrui Zhu Chen, María Paniagua-Sancho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 48
Adoptive cell therapy for cancer treatment
Shi Du, Jinyue Yan, Yonger Xue, et al.
Exploration (2023) Vol. 3, Iss. 4
Open Access | Times Cited: 45
Page 1 - Next Page

Scroll to top